NEWS
Novotech TPG’s top health play revealed today
SYDNEY: Australian clinical research firm Novotech is set to become one of the most successful… read more
UBS sounds caution on Cochlear prospects in near term
MELBOURNE: Cochlear remains in the exclusive club of ASX-listed shares costing more than $200, with… read more
ANDHealth now signs deal with US giant
NEW YORK: ANDHealth has penned a partnership with the innovation arm of the second largest… read more
